15 Drugs Chosen for Third Round of Medicare Price Negotiations
The Centers for Medicare and Medicaid Services has announced the drugs it has chosen for the third round of price negotiations between Medicare and drug manufacturers, including for the first time several drugs administered in doctors’ offices and other outpatient settings.
4 Questions About GLP-1s for Healthcare, Policy Leaders To Consider
As public and private payers decide whether to provide coverage for popular weight-loss drugs in the class known as glucagon-like peptide-1 receptor agonists, or GLP-1s, there are four key questions to consider.
ACHI Announces Promotions of Sandra McGrew, Jennifer Wessel, Joshua Cook
The Arkansas Center for Health Improvement (ACHI) announced Tuesday the promotions of Sandra McGrew to executive director, Jennifer Wessel to director of health policy, and Joshua Cook to director of external relations.
CMS Proposes New Medicare Payment Models Aimed at Lowering Drug Prices
The Centers for Medicare and Medicaid Services has proposed limited implementation of two new Medicare payment models aimed at bringing domestic drug prices down and making them comparable with those of peer countries.
